Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol with flurbiprofen axetil for painless X-ray hysterosalpingography
ChiCTR2400093113Phase 4Not yet recruiting
- Sponsor
- Liuzhou Maternal and Child Health Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in infertility (2 arms), sponsored by Liuzhou Maternal and Child Health Hospital. Primary endpoints: Mean arterial pressure, Intraoperative adverse reactions and 4 more. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2400093113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093113.